• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄和出血症状持续时间可最佳预测儿童免疫性血小板减少症在 3、6 和 12 个月时的缓解情况。

Age and duration of bleeding symptoms at diagnosis best predict resolution of childhood immune thrombocytopenia at 3, 6, and 12 months.

机构信息

Department of Pediatric Hematology/Oncology, Hadassah Hebrew-University Hospital, Jerusalem, Israel.

出版信息

J Pediatr. 2013 Nov;163(5):1335-9.e1-2. doi: 10.1016/j.jpeds.2013.06.018. Epub 2013 Jul 25.

DOI:10.1016/j.jpeds.2013.06.018
PMID:23891349
Abstract

OBJECTIVE

To evaluate the predictive value of clinical features at diagnosis of immune thrombocytopenia (ITP) for resolution of disease.

STUDY DESIGN

Hospital records of 472 consecutive children (<18 years old) with ITP cared for at 2 participating centers were reviewed retrospectively and data related to the initial presentation were recorded. Logistic regression analysis was used for calculating prediction of resolution at 3, 6, and 12 months from diagnosis.

RESULTS

The most significant predictors for resolution of ITP at 3, 6, and 12 months were age at onset <10 years and abrupt onset (history of <2 weeks of bleeding). We designed a prediction rule for ITP chronicity based on these criteria. The rate of developing chronic ITP for low, intermediate, and high risk children at diagnosis of ITP was 11%, 39%, and 63%, respectively. Recovery rate at 3 months for low, intermediate, and high risk children was 72%, 43% and 30%, respectively.

CONCLUSIONS

We present a simple rule to predict recovery from ITP at 3, 6, and 12 months from diagnosis. For prediction of resolution at 3 months, our rule was in agreement with the more complex, previously described Nordic score. Prediction of resolution of ITP may enable practitioners to better inform children and parents at the time of diagnosis, resulting in reduced anxiety and improved quality of life.

摘要

目的

评估免疫性血小板减少症 (ITP) 诊断时的临床特征对疾病缓解的预测价值。

研究设计

回顾性分析了 2 个参与中心收治的 472 例连续儿童 (<18 岁) 的 ITP 病例的医院记录,并记录了与初始表现相关的数据。采用逻辑回归分析计算从诊断后 3、6 和 12 个月的缓解预测。

结果

缓解 ITP 的最显著预测因素是发病年龄 <10 岁和突然发病(<2 周的出血史)。我们根据这些标准设计了一种 ITP 慢性预测规则。低、中、高危儿童在 ITP 诊断时发展为慢性 ITP 的发生率分别为 11%、39%和 63%。低、中、高危儿童在 3 个月时的恢复率分别为 72%、43%和 30%。

结论

我们提出了一种简单的规则来预测从诊断开始后 3、6 和 12 个月的 ITP 缓解。对于 3 个月时的缓解预测,我们的规则与之前描述的更复杂的北欧评分一致。ITP 缓解的预测可能使医生在诊断时更好地告知儿童及其家长,从而减轻焦虑并提高生活质量。

相似文献

1
Age and duration of bleeding symptoms at diagnosis best predict resolution of childhood immune thrombocytopenia at 3, 6, and 12 months.年龄和出血症状持续时间可最佳预测儿童免疫性血小板减少症在 3、6 和 12 个月时的缓解情况。
J Pediatr. 2013 Nov;163(5):1335-9.e1-2. doi: 10.1016/j.jpeds.2013.06.018. Epub 2013 Jul 25.
2
Predictive factors for resolution of childhood immune thrombocytopenia: Experience from a single tertiary center in Thailand.儿童免疫性血小板减少症缓解的预测因素:来自泰国一家三级中心的经验。
Pediatr Blood Cancer. 2017 Jan;64(1):128-134. doi: 10.1002/pbc.26178. Epub 2016 Aug 30.
3
Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.特发性血小板减少性紫癜:阿拉巴马儿童医院的一项为期10年的自然史研究。
Clin Pediatr (Phila). 2004 Oct;43(8):691-702. doi: 10.1177/000992280404300802.
4
[Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000].[1998 - 2000年丹麦儿童特发性血小板减少性紫癜的流行病学、疾病表现及病程]
Ugeskr Laeger. 2008 May 26;170(22):1922-6.
5
Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).静脉注射免疫球蛋白治疗儿童急性免疫性血小板减少症后慢性免疫性血小板减少症发生率可能较低——来自洲际合作免疫性血小板减少症研究组(ICIS)登记I的分析
Br J Haematol. 2009 Jul;146(2):180-4. doi: 10.1111/j.1365-2141.2009.07743.x. Epub 2009 May 19.
6
Outcome of chronic idiopathic thrombocytopenic purpura in children.儿童慢性特发性血小板减少性紫癜的转归。
Pediatr Blood Cancer. 2010 Mar;54(3):403-7. doi: 10.1002/pbc.22346.
7
Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS).儿童特发性血小板减少性紫癜:来自洲际儿童特发性血小板减少性紫癜研究组(ICIS)前瞻性登记I的12个月随访数据。
Pediatr Blood Cancer. 2006 Mar;46(3):351-6. doi: 10.1002/pbc.20453.
8
Prognostic variables in newly diagnosed childhood immune thrombocytopenia.新诊断儿童免疫性血小板减少症的预后变量
Am J Hematol. 2004 Dec;77(4):358-62. doi: 10.1002/ajh.20205.
9
[What is the prognosis of chronic immune thrombocytopenia?].[慢性免疫性血小板减少症的预后如何?]
An Pediatr (Barc). 2011 May;74(5):317-23. doi: 10.1016/j.anpedi.2010.09.035. Epub 2011 Feb 18.
10
Influence of the American Society of Hematology guidelines on the management of newly diagnosed childhood immune thrombocytopenia.美国血液学会指南对新诊断儿童免疫性血小板减少症管理的影响。
JAMA Pediatr. 2014 Oct;168(10):e142214. doi: 10.1001/jamapediatrics.2014.2214. Epub 2014 Oct 6.

引用本文的文献

1
Is less more? Intravenous immunoglobulin for pediatric immune thrombocytopenia.少即是多?静脉注射免疫球蛋白治疗儿童免疫性血小板减少症。
Ther Adv Hematol. 2024 Sep 17;15:20406207241279202. doi: 10.1177/20406207241279202. eCollection 2024.
2
Association of depression and social anxiety symptom scores with disease characteristics in pediatric patients with chronic immune thrombocytopenia: a cross-sectional study.慢性免疫性血小板减少症患儿抑郁和社交焦虑症状评分与疾病特征的相关性:一项横断面研究。
Int J Hematol. 2024 Sep;120(3):356-364. doi: 10.1007/s12185-024-03826-9. Epub 2024 Aug 1.
3
Predictor Factors for Chronicity in Immune Thrombocytopenic Purpura in Children.
儿童免疫性血小板减少性紫癜慢性化的预测因素
Children (Basel). 2023 May 23;10(6):911. doi: 10.3390/children10060911.
4
Predictors of Remission in Severe Childhood Immune Thrombocytopenia.儿童重症免疫性血小板减少症缓解的预测因素
Diagnostics (Basel). 2023 Jan 17;13(3):341. doi: 10.3390/diagnostics13030341.
5
The Use of Clinical Scores in the Management of Immune Thrombocytopenic Purpura in Children.临床评分在儿童免疫性血小板减少性紫癜管理中的应用
Front Pediatr. 2022 May 9;10:870064. doi: 10.3389/fped.2022.870064. eCollection 2022.
6
Chronic Pediatric Immune Thrombocytopenia Is Not Associated With Herpes Virus Infection Status.儿童慢性免疫性血小板减少症与疱疹病毒感染状态无关。
Front Pediatr. 2021 Dec 2;9:641535. doi: 10.3389/fped.2021.641535. eCollection 2021.
7
Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol.三期随机临床试验:比较艾曲泊帕与标准一线药物治疗方案用于儿童新诊断免疫性血小板减少症(ITP)的疗效:研究方案。
BMJ Open. 2021 Aug 27;11(8):e044885. doi: 10.1136/bmjopen-2020-044885.
8
A clinical prediction score for transient versus persistent childhood immune thrombocytopenia.儿童免疫性血小板减少症一过性与持续性的临床预测评分。
J Thromb Haemost. 2021 Jan;19(1):121-130. doi: 10.1111/jth.15125. Epub 2020 Nov 27.
9
Management strategies for newly diagnosed immune thrombocytopenia in Italian AIEOP Centres: do we overtreat? Data from a multicentre, prospective cohort study.意大利 AIEOP 中心新诊断免疫性血小板减少症的管理策略:我们是否过度治疗?来自一项多中心前瞻性队列研究的数据。
Blood Transfus. 2020 Sep;18(5):396-405. doi: 10.2450/2020.0041-20. Epub 2020 Jul 22.
10
Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia.慢性免疫性血小板减少症儿童中罗米司亭的长期治疗和无治疗血小板反应。
Haematologica. 2019 Nov;104(11):2283-2291. doi: 10.3324/haematol.2018.202283. Epub 2019 Mar 7.